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Abstract. 
 
Soluble factors are required to mediate nu-
clear export of protein and RNA through the nuclear
pore complex (NPC). These soluble factors include re-
ceptors that bind directly to the transport substrate and
regulators that determine the assembly state of re-
ceptor–substrate complexes. We recently reported the
identiﬁcation of NXT1, an NTF2-related export factor
that stimulates nuclear protein export in permeabilized
cells and undergoes nucleocytoplasmic shuttling in vivo
(Black, B.E., L. Lévesque, J.M. Holaska, T.C. Wood,
 
and B.M. Paschal. 1999. 
 
Mol. Cell. Biol.
 
 19:8616–8624).
Here, we describe the molecular characterization of
NXT1 in the context of the Crm1-dependent export
pathway. We ﬁnd that NXT1 binds directly to Crm1,
and that the interaction is sensitive to the presence of
Ran-GTP. Moreover, mutations in NXT1 that reduce
binding to Crm1 inhibit the activity of NXT1 in nuclear
export assays. We show that recombinant Crm1 and
Ran are sufﬁcient to reconstitute nuclear translocation
of a Rev reporter protein from the nucleolus to an anti-
body accessible site on the cytoplasmic side of the NPC.
Further progress on the export pathway, including the
terminal step of Crm1 and Rev reporter protein re-
lease, requires NXT1. We propose that NXT1 engages
with the export complex in the nucleoplasm, and that it
facilitates delivery of the export complex to a site on
the cytoplasmic side of NPC where the receptor and
substrate are released into the cytoplasm.
Key words: nuclear transport • NES • Crm1 • Ran •
NXT1
 
Introduction
 
Protein and RNA transport across the nuclear envelope
 
(NE)
 
1 
 
occurs through specialized channels termed nuclear
pore complexes (NPCs) (Gorlich and Kutay, 1999; Nak-
ielny and Dreyfuss, 1999). The NPC is estimated to con-
 
tain 
 
.
 
50 different proteins, which assemble into a su-
 
pramolecular structure (
 
z
 
125 mD) that spans the double
membrane of the NE (Stoffler et al., 1999; Wente, 2000).
The NPC contains a central channel that mediates facili-
tated import and export of a large variety of transport sub-
strates. The specificity of transport, that is to say whether a
macromolecule undergoes import or export, generally re-
quires a cis-acting nuclear localization signal (NLS) or a
nuclear export signal (NES). These signals are recognized
by transport receptors, which mediate interactions with
the NPC and facilitate translocation of the macromolecule
to the appropriate compartment.
 
Most of the receptors for import and export described to
 
date are members of the importin-
 
b
 
 (also called karyo-
pherin-
 
b
 
) superfamily of proteins. This includes Crm1, the
nuclear export receptor for NES-containing proteins, such
as protein kinase inhibitor (PKI) (Wen et al., 1995; For-
nerod et al., 1997; Stade et al., 1997). In the nucleus, Ran-
GTP stabilizes Crm1 binding to NES-containing proteins,
resulting in the formation of a trimeric export complex
(Fornerod et al., 1997). The physical basis of export com-
plex translocation through the NPC, including the mecha-
nisms that influence the direction of export complex move-
ment through the NPC, have not been defined. There is
also limited data addressing the terminal step of export,
which refers to the posttranslocation events that result in
disassembly of the export complex, and in the case of
Crm1, release of its NES-containing cargo into the cyto-
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plasm. One key component in the terminal step of export is
Ran-GTP, which has the capacity to serve as a molecular
switch to terminate both NES binding to Crm1, and Crm1
binding to the NPC (Fornerod et al., 1997; Kehlenbach et
al., 1999). The terminal step of export could occur when a
protein binds Ran-GTP and dissociates it from the export
complex. The Ran-binding protein RanBP1, or RanBP1-
like domains in the nucleoporin RanBP2, are candidates
for promoting the dissociation reaction in this manner (Keh-
lenbach et al., 1999). Alternatively, RanGAP could acti-
vate the Ran GTPase in the context of the export complex,
perhaps using RanBP1 as a cofactor, and convert GTP to
GDP (Bischoff et al., 1995; Askjaer et al., 1999; Paraskeva
et al., 1999). Because of its extremely low affinity for
Crm1, Ran-GDP would rapidly dissociate from the com-
plex, resulting in NES release from Crm1. RanGAP could
also function in the dissociation-based mechanism by acti-
vating the GTPase activity of Ran-GTP that has already
dissociated from the export complex. In both cases, Ran-
GAP-dependent conversion of Ran-GTP to Ran-GDP
would make export complex reassembly unfavored, mak-
ing the disassembly reaction essentially irreversible. These
models for terminating export are consistent with the elec-
tron microscopic immunolocalization of RanGAP and
RanBP2 on the cytoplasmic side of the NPC (Matunis et
al., 1996; Mahajan et al., 1997), as well as the cytoplasmic
distribution of RanBP1 (Richards et al., 1996).
The mechanisms of nuclear import and export are of in-
terest because of their importance to basic cell physiology
and their relevance to the life cycles of medically impor-
tant viruses. Retroviruses, such as HIV-1, require specific
interactions with the host cell machinery for both nuclear
import and export of viral proteins and nucleic acids
(Stevenson, 2000). Integration of the viral genome into the
DNA of nondividing cells requires translocation of the
preintegration complex through the NPC in a mechanism
that involves importin-
 
b
 
 as the import receptor. Transcrip-
tion of the viral genome generates an 
 
z
 
13-kb RNA, which
is exported to the cytoplasm and used as the template for
protein synthesis and virion production (Cullen, 2000).
Nuclear export of HIV-1 RNA depends on a cis-acting sig-
nal within the RNA, which is termed the Rev response ele-
ment (RRE) (Malim et al., 1989). The RRE provides the
binding site for Rev, an HIV-1 protein whose leucine-rich
NES is, in turn, recognized by the host export machinery
(Fischer et al., 1995). This occurs when the export receptor
Crm1 binds to the NES of Rev, an interaction that is stabi-
lized by Ran-GTP. Current models suggest that a complex
consisting of RRE RNA, Rev, Crm1, and Ran-GTP as-
sembles in the nucleoplasm and undergoes translocation
through the NPC (Gorlich and Kutay, 1999; Nakielny and
Dreyfuss, 1999). In the absence of an efficient pathway for
nuclear export, HIV-1 RNA is subject to nuclear retention
and splicing because it contains introns (Sodroski et al.,
1986). Thus, nuclear export of full-length genomic RNA is
necessary for viral replication.
In previous work, we identified a protein we named
NXT1 for NTF2-related export protein 1 (Black et al.,
1999). The evolutionary relatedness of NXT1 and NTF2
(26% identity) suggests these proteins should have related
functions in the cell. We found that NTF2 binds Ran-GDP
and functions in nuclear import (Moore and Blobel, 1994;
Paschal and Gerace, 1995; Paschal et al., 1996), and that
 
NXT1 binds Ran-GTP and functions in nuclear export
(Black et al., 1999). Both NXT1 and NTF2 are nuclear
proteins, and NXT1 shuttles between the nucleus and cy-
toplasm. One striking difference is that the steady-state
distribution of NXT1 includes the NPC. The NPC localiza-
tion of NXT1 persists after digitonin permeabilization of
the plasma membrane, a condition that releases many sol-
uble proteins from the cell. Evidence that NXT1 is an ex-
port factor was obtained by showing that the recombinant
protein stimulates nuclear export of PKI in permeabilized
cells (Black et al., 1999). NXT1-dependent export of PKI
required the addition of cytosol and could be blocked by
the Crm1-specific inhibitor leptomycin B (LMB) (Wolff et
al., 1997). These findings, together with more recent data
showing that NXT1 can stimulate nuclear export of U1
snRNA in permeabilized cells (Ossareh-Nazari et al., 2000),
led us to conclude that NXT1 functions on an export path-
way for which Crm1 is the receptor.
NXT1, which has been referred to as p15, has also been
described as a cofactor for a viral RNA export pathway for
which a protein termed TAP is the receptor (Katahira et
al., 1999). TAP can bind directly to the constitutive trans-
port element (CTE) of transcripts encoded by the Mason-
Pfizer monkey virus (Hammarskjöld, 1997), and it can
stimulate nuclear export of the RNA in oocytes (Gruter et
al., 1998). Although NXT1 binds directly to TAP (Katahira
et al., 1999; Lévesque, L., and B.M. Paschal, unpublished
observations), there is no data addressing how this interac-
tion regulates CTE RNA export. The host cell function of
the NXT1–TAP interaction may involve nuclear export of
mRNA. This prediction is based on the relatedness of TAP
to the mRNA export factor Mex67p (23% identity, expec-
tation value 10
 
2
 
11
 
), and the fact that coexpression of NXT1
and TAP can rescue the viability of a 
 
mex67
 
 mutant in 
 
Sac-
charomyces cerevisiae 
 
(Katahira et al., 1999).
Here, we have characterized the molecular function of
NXT1 in Crm1-mediated nuclear export. We have used a
cell-based assay and recombinant factors to reconstitute
nuclear export of a Rev reporter protein. We find that
Crm1 and Ran are sufficient to reconstitute Rev transport
from the nucleolus to the cytoplasmic side of the NPC.
This likely reflects the accumulation or arrest of the export
complex at an intermediate step in the pathway. We dem-
onstrate that NXT1 is required for progression through
the terminal step in the nuclear export pathway, resulting
in the release of Crm1 and Rev from the cytoplasm side of
the NPC. The terminal step also requires RanBP1 as a co-
factor, which may reflect RanBP1- and RanGAP-depen-
dent conversion of Ran-GTP to Ran-GDP as part of the
release mechanism. We show that NXT1 binds directly to
Crm1, and a point mutation in NXT1 that reduces Crm1
binding also reduces its export activity. Our results indi-
cate that NXT1 is a cofactor that facilitates the terminal
step in Crm1-dependent export.
 
Materials and Methods
 
Rev Export Assay
 
Rev export was monitored using a cell line (RGG2.2) (Love et al., 1998)
expressing Rev fused to the ligand-binding domain of the glucocorticoid
receptor (GR) and green fluorescent protein (GFP). In brief, nuclear ac-
cumulation of the Rev–GR–GFP is stimulated by the addition of 1 
 
m
 
M
dexamethasone for 30 min to RGG2.2 cells growing on coverslips in DME 
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containing 10% newborn calf serum. Cells are permeabilized with digito-
nin (0.005%) for 5.5 min. This was followed by a 4-min incubation in
transport buffer (20 mM Hepes, pH 7.4, 110 mM potassium acetate, 2 mM
magnesium acetate, 1 mM EGTA) supplemented with 300 mM NaCl to
release NXT1 from the NPC. Standard export reactions (50 
 
m
 
l) were car-
ried out at 30
 
8
 
C for 30 min using the combinations of recombinant pro-
teins stated in the figure legends. A protease inhibitor cocktail, which con-
sisted of leupeptin and pepstatin (each at 1 
 
m
 
g/ml), as well as 2 mM DTT,
was included in all transport reactions. HeLa cell cytosol was prepared, as
described previously (Holaska and Paschal, 1998), and used at 3 mg/ml as
a positive control for nuclear export. Phenyl-Sepharose treatment of cyto-
sol to deplete Crm1 was performed as described previously (Holaska and
Paschal, 1998). The order of addition experiments (see Fig. 4) are two-
step export reactions that involve a standard export reaction, a wash step,
and an additional 30-min incubation with the indicated factors. Cells from
both standard and two-step export reactions were fixed with formalde-
hyde, stained with DAPI, and mounted using Vectashield medium (Vec-
tor Laboratories). Digital images were captured by a charged-coupled de-
vice camera (Hamamatsu ORCA) mounted on a Nikon Microphot-SA
microscope, using Openlab (version 2.0.6) software. Figures were assem-
bled using Adobe Photoshop
 
®
 
 (version 5.5) and Freehand (version 8.0).
Images were captured with the same exposure times within an experi-
ment. All images shown are representative of the results from multiple ex-
periments.
 
Anti-GFP Detection Assay
 
For experiments involving antibody-based detection of Rev–GR–GFP,
cells were fixed in 2% formaldehyde for 10–15 min. This relatively light
fixation maintains NE integrity. Samples were incubated in a blocking so-
lution containing PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na
 
2
 
HPO
 
4
 
, 1.76
mM KH
 
2
 
PO
 
4
 
, pH 7.4) supplemented with 2% BSA and 2% newborn calf
serum for 45 min. The affinity-purified anti-GFP rabbit polyclonal anti-
body (provided by Pamela Silver, Harvard University, Cambridge, MA)
(Seedorf et al., 1999) was used at 1:20,000 for detection of Rev–GR–GFP.
To visualize NPCs, a pan-nucleoporin mAb (RL1) (provided by Larry
Gerace, The Scripps Research Institute, La Jolla, CA) (Snow et al., 1987)
was used at 1:100. To visualize Crm1 in Rev–GR–GFP export assays, cells
were fixed lightly and incubated with an anti-Crm1 rabbit polyclonal anti-
body (provided by Ralph Kehlenbach, The Scripps Research Institute, La
Jolla, CA) (Kehlenbach et al., 1998) diluted 1:1,000. Goat anti–rabbit Cy3-
conjugated secondary antibody and goat anti–mouse Cy3-conjugated sec-
ondary antibodies were obtained from Jackson ImmunoResearch Labora-
tories.
 
PKI Export Assay
 
The PKI export assays were performed in suspension-culture HeLa cells,
as described previously (Holaska and Paschal, 1998). In brief, nuclear im-
port of FITC–streptavidin (STV)–NLS in digitonin permeabilized cells is
mediated by the phenyl-Sepharose–treated cytosol, which is depleted of
Crm1, as assayed by immunoblotting (Holaska and Paschal, 1998). Biotin-
ylated PKI enters the nucleus via diffusion and binds the FITC–STV–
NLS. Export reactions were performed using the indicated export factors,
the samples were fixed, and mounted on slides. Nuclear export in this as-
say is not dependent on the addition of recombinant RanBP1. This is
likely due to the fact that the cytosol used to drive the import of FITC–
STV–NLS contains RanBP1, and it is not released efficiently during the
wash step between the import and export steps of the assay. Nuclear ex-
port was quantitated by measuring the reduction of nuclear fluorescence
that occurs upon the addition of export factors (Holaska and Paschal,
1998). The reduction in nuclear fluorescence in our assay is a result of nu-
clear export and not degradation of FITC–STV–NLS (Holaska and Pas-
chal, 1998; data not shown).
 
Recombinant Proteins
 
The export factors used to reconstitute nuclear export were expressed as
recombinant proteins in bacteria and stored at 
 
2
 
80
 
8
 
C as single-use ali-
quots. The expression and purification of His-tagged Ran (Gorlich et al.,
1994), glutathione-
 
S
 
-transferase (GST)–tagged Ran (Richards et al.,
1995), His-tagged Crm1 (Englmeier et al., 1999), GST-tagged RanBP1 (ei-
ther intact or thrombin-cleaved) (Richards et al., 1995), and biotinylated
PKI (Holaska and Paschal, 1998) has all been described. Wild-type NXT1
(sequence data available from GenBank/EMBL/DDBJ under accession
no. AF156958) expression and purification from the inclusion body frac-
tion has been described previously (Black et al., 1999). Point mutations in
 
the NXT1 open reading frame were generated in the bacterial expression
vector using the QuickChange site-directed mutagenesis system (Strat-
agene). The COOH-terminal truncation was generated in a PCR reaction
that amplified the NXT1 open reading frame, with a stop codon engi-
neered to remove the final four codons. The protocol used for expression
and purification of the wild-type NXT1 protein was used for the mutant
NXT1 proteins.
 
Protein-binding Assays
 
Solid-phase Ran-binding assays have been described previously (Black et
al., 1999). In brief, recombinant proteins were adsorbed to microtiter wells
(5 
 
m
 
g NXT1 added/well, each well with a capacity of 
 
z
 
20 ng), which was
followed by extensive wash and blocking steps (Black et al., 1999). Ran,
preloaded with [
 
g
 
-
 
32
 
P]GTP or [
 
a
 
-
 
32
 
P]GTP, was incubated in wells contain-
ing the indicated proteins immobilized in high-binding 96-well plates
(Corning). Similarly, [
 
35
 
S]Crm1 (Ossareh-Nazari and Dargemont, 1999),
expressed in reticulocyte lysate, was incubated in wells containing the in-
dicated immobilized proteins. The radiolabeled proteins that bound to the
wells were eluted with SDS and quantitated by scintillation counting. Ran
or Crm1 binding to BSA-coated wells was designated background and
subtracted from the wells containing the immobilized recombinant pro-
teins in both radiolabel and ELISA detection methods.
Recombinant Crm1 binding in the solid-phase assays was measured by
ELISA (Delphin et al., 1997) using an anti-Crm1 antibody. After the
binding reaction, wells were washed 3
 
3
 
, and the anti-Crm1 antibody (1:
1,000) was incubated in 0.5
 
3
 
 transport buffer containing 0.2% Tween 20
and 1% BSA for 2 h at room temperature. Wells were washed 5
 
3
 
 and
goat anti–rabbit horseradish peroxidase–coupled secondary antibody
(Pierce Chemical Co.) was incubated in the same buffer for 1 h at room
temperature. Horseradish peroxidase activity was measured, using 2,2
 
9
 
azino-di-(3-ethylbenzthiozoline sulfonic acid) as a colorimetric substrate,
on a microplate reader (ELX800; Bio-Tek Instruments, Inc.) to measure
the absorbance at 410 nm. NXT1 binding in solid-phase assays was ana-
lyzed by immunoblot using a rabbit polyclonal antibody raised against a
peptide (CGTVKFEGNKQRDFNQN) that corresponds to an internal
sequence in mouse NXT1. All binding assays were performed in duplicate
and the values shown represent the mean 
 
6 
 
SD.
 
RNA Export Assays
 
U1 snRNA, mRNA, and tRNA export assays in permeabilized HeLa cells
have been described previously (Ossareh-Nazari et al., 2000). After the
export reactions, samples were centrifuged at 210 
 
g
 
 for 5 min to separate
nuclear and supernatant fractions. Radiolabeled RNA was visualized after
separation on an 8% acrylamide gel containing 7 M urea. The level of ex-
port was quantitated using the Bioprint acquisition system and Bioprofil
software. The values for RNA export correspond to the ratio of RNA in
the supernatant fraction to the sum of RNA present in the nuclear and su-
pernatant fractions. Quantitation of U1 snRNA and tRNA export is from
three independent experiments. Quantitation for mRNA export is from
two independent experiments.
 
Results
 
NXT1 Stimulates Rev Export
 
NXT1 is a Ran-GTP–binding protein predicted to func-
tion on Crm1-dependent export pathways, based on two
observations. First, recombinant NXT1 stimulates nuclear
export of the Crm1-transport substrates PKI (Black et al.,
1999) and U1 snRNA (Ossareh-Nazari et al., 2000) in
permeabilized cells supplemented with cytosol. Second,
NXT1-stimulated export of PKI in permeabilized cells is
blocked by the addition of LMB (Black et al., 1999), a
highly specific inhibitor of Crm1 function. We set out to
characterize how NXT1 may regulate Crm1-dependent
export using recombinant factors and permeabilized cell
assays that reconstitute nuclear export of NES-containing
fluorescent reporter proteins.
We used a cell line that expresses the NES-containing
protein Rev fused to the ligand-binding domain of GR and
GFP, which undergoes nuclear import after dexametha- 
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sone addition (Love et al., 1998). The Rev–GR–GFP fu-
sion concentrates in nucleoli, and after digitonin perme-
abilization, undergoes cytosol-dependent nuclear export
(Fig. 1; and Love et al., 1998). We observed that Rev–GR–
GFP translocation from nucleoli to the NPC, indicated by
the accumulation of fluorescence at the NE, requires the
addition of Ran and Crm1 (Fig. 1). We found that NXT1
stimulates Ran and Crm1-dependent export, resulting in a
marked reduction in both nucleolar- and NE-associated
fluorescence. NXT1-stimulated export of Rev–GR–GFP
was blocked by LMB (Fig. 1). This is consistent with our
previous data showing that NXT1 stimulation of PKI ex-
port can be blocked by LMB (Black et al., 1999). A low
level of Rev–GR–GFP was detected at the NE in the reac-
tion containing Ran, Crm1, and NXT1, which was absent
in the reaction containing cytosol (Fig. 1). This suggests
that additional factors, such as RanBP1, may be required
for highly efficient release of NES substrate from the NPC
in permeabilized cells (see below). In summary, these data
indicate that NXT1, Crm1, and Ran-GTP function cooper-
atively to mediate nuclear export of the NES substrate
Rev–GR–GFP.
 
NXT1 Facilitates Late Events in the NES
Export Pathway
 
The Crm1- and Ran-dependent accumulation of Rev–
GR–GFP at the NE is likely to represent its association
with the NPC. We confirmed this by showing that the
Rev–GR–GFP signal is coincident with the NPC (Fig. 2,
NE Permeabilized, 
 
a
 
-NPC), using the pan-nucleoporin an-
tibody RL1 (Snow et al., 1987). To determine whether
Rev–GR–GFP accumulation occurs on the nuclear or cy-
toplasmic side of the NPC, we used an antibody to GFP
(Seedorf et al., 1999) and stained the cells after permeabi-
lization with digitonin. Since the NE remains intact under
this condition, the cytoplasmic side of the NPC is accessi-
ble to the antibody, whereas the nucleoplasmic side is not.
Using the anti-GFP detection assay, we found that Rev–
GR–GFP accumulates on the cytoplasmic side of the NPC
in the presence of Crm1 and Ran (Fig. 2, NE Intact, 
 
a
 
-GFP),
but not in the absence of these factors (see below). Pre-
treatment of cells with 1% Triton X-100 resulted in per-
meabilization of the NE and detection of GFP in both
compartments (Fig. 2, NE Permeabilized). Thus, a com-
plex consisting minimally of Crm1, Ran-GTP, and Rev–
GR–GFP is delivered to the cytoplasmic side of the NPC
in our permeabilized cell assay, and it can be revealed by
antibody detection.
We used our anti-GFP detection assay to define the bio-
chemical requirements for Rev–GR–GFP release from the
cytoplasmic face of the NPC, which is likely to represent the
terminal step in nuclear export. We found that whereas Ran
and Crm1 promote Rev–GR–GFP delivery to the cytoplas-
 
(
 
1
 
Ran
 
1
 
Crm1
 
1
 
NXT1
 
1
 
LMB). NXT1 had no effect in export reac-
tions supplemented with Ran or Crm1 separately (data not shown).
The fields shown were captured using a 60
 
3
 
 oil immersion objec-
tive, and the NXT1 stimulation of Rev–GR–GFP export
(
 
1
 
Ran
 
1
 
Crm1
 
1
 
NXT1) is representative of the effect observed in
25 separate experiments.
 
Figure 1.
 
NXT1 cooperates with Crm1 and Ran to mediate the nu-
clear export of Rev. Rev export assays were performed in permeabi-
lized cells expressing Rev–GR–GFP (Love et al., 1998). Ran (1.5
 
m
 
M) and Crm1 (16 nM), when present in the same reaction, pro-
mote the accumulation of Rev–GR–GFP export substrate at the NE
(
 
1
 
Ran
 
1
 
Crm1). This accumulation was observed when either re-
combinant His-tagged Crm1 (shown here) or Crm1 purified from
HeLa cytosol (data not shown) was used in reactions containing
Ran. NXT1 (17 
 
m
 
M) stimulated nuclear export when both Ran and
Crm1 were present in the reaction (
 
1
 
Ran
 
1
 
Crm1
 
1
 
NXT1), and this
export was sensitive to the Crm1-specific inhibitor LMB (500 nM) 
Black et al. 
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mic face of the NPC, including NXT1 in this reaction signif-
icantly reduced the level of cytoplasm-exposed Rev–GR–
GFP (Fig. 3, 
 
1
 
Ran
 
1
 
Crm1
 
1
 
NXT1). We also examined the
ability of RanBP1 to promote Rev–GR–GFP release from
the NPC, since it has been shown previously to act as a co-
factor for NES cargo release (Kehlenbach et al., 1999). In-
cluding recombinant RanBP1 in the export reaction with
Ran-GTP and Crm1 had little effect on the level of Rev–
GR–GFP detected on the cytoplasmic side of the NPC, and
RanBP1 did not appear to stimulate nuclear export of Rev–
GR–GFP, as judged by the bright nucleolar fluorescence
in cells at the end of the export reaction (Fig. 3,
 
1
 
Ran
 
1
 
Crm1
 
1
 
RanBP1). However, we found that includ-
ing both NXT1 and RanBP1 in the reaction promoted the
complete release of Rev–GR–GFP from the cytoplasmic
side of the NPC, as well as a dramatic reduction in nucleolar
fluorescence (Fig. 3, 
 
1
 
Ran
 
1
 
Crm1
 
1
 
NXT1
 
1
 
RanBP1). Our
finding that Ran, Crm1, NXT1, and RanBP1 are sufficient
for Rev–GR–GFP delivery to, and release from, the cyto-
plasmic side of the NPC suggests these are the minimal sol-
Figure 2. Rev–GR–GFP accumulates at the cytoplasmic face of the NPC in a reaction containing Crm1 and Ran. Export reactions were
performed in the presence of Crm1 (16 nM) and Ran (1.5 mM). NPCs were detected with a pan-nucleoporin antibody (RL1) (Snow et
al., 1987) to reveal punctate staining at the NE. In cells that were treated with detergent (1% Triton X-100), the anti-GFP antibody has
access to the nucleoplasm, and the staining pattern is coincident with the GFP signal observed in the FITC channel. In cells that were
not treated with detergent, NE integrity is maintained. Under this latter condition, the anti-GFP antibody cannot enter the nucleus,
though robust punctate staining is present on the NE of cells expressing Rev–GR–GFP. Cells not expressing Rev–GR–GFP do not
show any anti-GFP staining, illustrating the specificity of the antibody and conditions used in this assay. 
The Journal of Cell Biology, Volume 152, 2001 146
Figure 3. NXT1 facilitates the release of Rev–GR–GFP from the NPC. Rev export reactions were performed in the presence of the indicated
factors. Rev–GR–GFP on the cytoplasmic face of the NPC was visualized using the anti-GFP antibody under conditions where the integrity
of the NE is maintained. The addition of NXT1 (17 mM) to a reaction containing Ran (1.5 mM) and Crm1 (16 nM) caused a marked decrease
in Rev–GR–GFP on the cytoplasmic face of the NPC (1Ran1Crm11NXT1). RanBP1 (1.7 mM) had a modest effect when added alone to a
reaction containing Ran and Crm1 (1Ran1Crm11RanBP1), but completely released the Rev–GR–GFP remaining on the cytoplasmic face
of the NPC when added to a reaction containing Ran, Crm1, and NXT1 (1Ran1Crm11NXT11RanBP1). Cytosol, when added to the Ran-
and Crm1-containing reaction, also releases Rev–GR–GFP from the cytoplasmic face of the NPC (1Ran1Crm11Cytosol). The GFP signal
is shown for each sample to illustrate the level of export that occurs under each of these conditions. 
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Figure 4. Order of addition experiment indicating the requirement for Ran, Crm1, and NXT1 early in the export pathway. Rev export re-
actions were performed in two steps. The first step was a standard export reaction using the proteins indicated (Ran1Crm1 or
Ran1Crm11NXT1). The samples were then washed twice, and incubated during the second step with buffer or the proteins indicated.
Ran was used at 1.5 mM, Crm1 was used at 16 nM, and NXT1 was used at 17 mM. NXT1, added in a second step, promotes little Rev–GR–
GFP release. In contrast, when NXT1 is included in the first step, we observe nearly complete release of Rev–GR–GFP. When Ran (1.5
mM), preloaded with GTP, is added in a second step, it does not release Rev–GR–GFP from the cytoplasmic face of the NPC. However,
Rev–GR–GFP can be released by the addition of cytosol (3 mg/ml). Phenyl-Sepharose–treated cytosol (PS cytosol), which is depleted of
Crm1 (Holaska and Paschal, 1998), is less active than untreated cytosol in releasing Rev–GR–GFP from the cytoplasmic face of the NPC,
suggesting a role for Crm1 in this reaction. Note that RanBP1 (1.7 mM) was included in the first and second steps of all reactions. 
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uble components for this transport pathway. It also impli-
cates NXT1 and RanBP1 as essential factors for the
terminal step of nuclear export.
The molecular basis of NXT1-dependent Rev–GR–GFP
release from the NPC is likely to reflect its interaction with
the export complex containing Ran and Crm1. For exam-
ple, NXT1 could assemble into the export complex in the
nucleoplasm and function as a subunit that specifies target-
ing to, and release from, a nucleoporin oriented on the cy-
toplasmic side of the NPC. Alternatively, NXT1 might in-
teract transiently with the export complex after it arrives on
the cytoplasmic side of the NPC and promote Rev–GR–
GFP release. We addressed this issue in permeabilized cells
with a two-step order of addition experiment. In the first
 
step, we added Ran and Crm1 to drive accumulation of
Rev–GR–GFP at the antibody accessible site on the cyto-
plasmic side of the NPC. In the second step, we added the
indicated factors, and subsequently determined the level
of Rev–GR–GFP on the cytoplasmic side of the NPC.
RanBP1 was included in both steps of these reactions, since
it promotes nuclear export in our system (Fig. 3). We found
that NXT1 addition in the second step had little effect on
the level of Rev–GR–GFP detected at the NPC (Fig. 4,
Ran
 
1
 
Crm1
 
®
 
NXT1). This suggests that NXT1 does not
stimulate Rev–GR–GFP release through a simple transient
interaction with the export complex. It also indicates that
NXT1 probably interacts with the export complex in an
early step of export, before the arrival of the export com-
Figure 5. NXT1 stimulates the release of Crm1 from the NPC. Crm1 was detected by indirect immunofluorescence using a Crm1 antibody
(Kehlenbach et al., 1998). Because the integrity of the NE was maintained throughout the antibody incubations, the Crm1 signal (red) rep-
resents Crm1 that has accumulated on the cytoplasmic face of the NPC. In reactions performed without recombinant transport factors
(1Buffer), background levels of Crm1 were detected, probably corresponding to the endogenous export receptor. Crm1 (16 nM) addition
results in near background levels of Crm1 detected on the cytoplasmic face of the NPC (1Crm1). The addition of Crm1 (16 nM) and Ran
(1.5 mM) to the reaction causes the accumulation of Rev–GR–GFP at the NE. Under these conditions, high levels of Crm1 are visualized
on the cytoplasmic face of the NPC (1Ran1Crm1). Including NXT1 (17 mM) in the reaction stimulates the release of Crm1 from the cyto-
plasmic face of the NPC, and a pronounced increase in total Rev–GR–GFP export (1Ran1Crm11NXT1). The reduction in Crm1 stain-
ing at the NPC probably reflects a NXT1-dependent release reaction, though it is formally possible that NXT1 simply prevents Crm1 accu-
mulation on the cytoplasmic side of the NPC. The latter possibility is unlikely, given that NXT1 addition results in robust stimulation of
Rev–GR–GFP export. Export reactions containing recombinant transport factors were supplemented with RanBP1 (1.7 mM).Black et al. NXT1 Promotes the Terminal Step of Nuclear Export 149
plex on the cytoplasmic side of the NPC. However, the ac-
tivity of NXT1 is manifest in a late step of export, which in-
cludes substrate release into the cytoplasm.
Because NXT1 is a Ran-GTP–binding protein that shut-
tles between the nucleus and cytoplasm, we considered the
formal possibility that its nuclear export function involves
nuclear export of Ran-GTP. That is, NXT1 could facilitate
the delivery of Ran-GTP from the nucleoplasm to the cy-
toplasm. Hypothetically, Ran-GTP could be used to disso-
ciate export complexes on the cytoplasmic side of the
Figure 6. NXT1 binds di-
rectly to the export complex.
(A) Crm1 specifically inter-
acts with NXT1 in solid-
phase binding assays. Values
shown correspond to rela-
tive amounts of [35S]Crm1
bound as a percent of bind-
ing to NXT1 wells in the ab-
sence of RanGAP (3,221 6
215 cpm of [35S]Crm1 bound
in this condition). Crm1
binding is 12-fold higher in
NXT1 wells compared with
the binding to NTF2 wells.
Pretreatment of the binding
reaction with RanGAP,
which converts the Ran-GTP
present in the reticulocyte ly-
sate to Ran-GDP, reduces
Crm1 binding to NXT1 to
45.5 6 0.4% of that observed
in the absence of RanGAP.
(B) NXT1 binds directly to
Crm1, and binding is stimu-
lated by the addition of Ran
preloaded with GMP-PNP.
A concentration range of re-
combinant Crm1 was added
to NXT1 wells in the pres-
ence (j) or absence (r) of
500 nM Ran. A 20-amino
acid peptide containing the
NES of PKI (500 nM) was in-
cluded in the binding reac-
tions. (C and D) NXT1 does
not affect the affinity of
Crm1 for NES substrate. Re-
actions were performed in
the presence of Ran (200
nM) that had been preloaded
with GMP-PNP. In C, either
wild-type or the NES mutant
(L41,44A) (Wen et al., 1995)
recombinant PKI protein
was immobilized in microti-
ter wells. Binding reactions
containing Crm1 (2.5 nM)
that was preincubated in the
absence or presence of LMB
(500 nM) were added to the
PKI wells. The interaction
between Crm1 and PKI is
specific for the wild-type
NES and is blocked by LMB. In D, a concentration range of Crm1 was tested in the presence (j) or absence (r) of 50 nM NXT1 in
PKI-containing wells. (E) NXT1 has little effect on Ran-GTP stabilization on immobilized Crm1. The NES peptide (500 nM) was in-
cluded in the binding reactions. A concentration range of Ran, preloaded with [a-32P]GTP, was added to wells containing immobilized
Crm1 in the presence (j) or absence (r) of 50 nM NXT1. (F) NXT1 binds to Ran, but not RanBP1. NXT1 (500 nM) was added to wells
containing immobilized GST-Ran, GST-RanBP1, or GST. Bound protein was eluted in SDS-PAGE sample buffer, and analyzed by im-
munobloting using an anti-peptide antibody to NXT1. NXT1 was found to bind directly to GST-Ran, but not to GST-RanBP1 or GST.
GST-RanBP1 immobilized in microtiter wells is functional, as assessed by Ran-binding assays (Steggerda and Paschal, 2000).The Journal of Cell Biology, Volume 152, 2001 150
NPC. NTF2 appears to perform what might be considered
a reciprocal function, because it facilitates the delivery of
Ran-GDP from the cytoplasm to the nucleoplasm, and af-
ter nucleotide exchange, Ran-GTP is used to dissociate
import complexes on the nucleoplasmic side of the NPC. If
the primary function of NXT1 is to deliver Ran-GTP to
the cytoplasm, then addition of excess Ran-GTP should
promote release of Rev–GR–GFP from the cytoplasmic
side of the NPC. However, we found that Ran-GTP addi-
tion does not stimulate Rev–GR–GFP release from the
NPC (Fig. 4, Ran1Crm1®Ran-GTP). Importantly, the
Rev–GR–GFP in this assay is not irreversibly arrested on
the cytoplasmic side of the NPC, since it can be released
by the addition of cytosol (Fig. 4, Ran1Crm1®Cytosol).
This may reflect the presence of a soluble-release activity
that acts directly on the export complex. Alternatively, re-
lease of Rev–GR–GFP might occur when export com-
plexes assemble from HeLa cytosol–derived Crm1. Newly
assembled export complexes could then promote dissocia-
tion of preexisting export complexes by competing for a
limited number of binding sites on the cytoplasmic side of
the NPC. We addressed this using cytosol pretreated with
phenyl-Sepharose to remove Crm1 (Holaska and Paschal,
1998). Addition of phenyl-Sepharose–treated cytosol (PS
Cytosol) was much less effective than control cytosol in
promoting Rev–GR–GFP release (Fig. 4, Ran1Crm1®PS
Cytosol), and nucleolar fluorescence remained signifi-
cantly brighter in the phenyl-Sepharose–treated cytosol
samples. Whereas these results do not rule out a role for a
soluble release activity, they suggest that cytosolic Crm1
and the ongoing assembly and translocation of export
complexes may represent part of the release mechanism
for preexisting export complexes.
We addressed whether the function of NXT1 in the ter-
minal step of export also involves the release of the recep-
tor Crm1 from the NPC. We performed Rev–GR–GFP ex-
port assays, and monitored the level of Crm1 localized to
the cytoplasmic face of the NPC by immunofluorescence
microscopy. The antibody approach for Crm1 detection in
this experiment is similar to that used to detect Rev–GR–
GFP (Figs. 2–4), where the integrity of the NE is main-
tained. Using a Crm1 antibody (Kehlenbach et al., 1998),
we observed a high level of Crm1 accumulation on the
cytoplasmic face of the NPC that was dependent upon
the addition of recombinant Ran and Crm1 (Fig. 5,
1Ran1Crm1). A visible accumulation of Rev–GR–GFP
at the NE was only observed in the presence of both Ran
and Crm1, suggesting these proteins may be part of an ex-
port complex situated on cytoplasmic face of the NPC. In-
cluding NXT1 in the reaction caused a substantial reduc-
tion in the level of Crm1 on the cytoplasmic face of the
NPC (Fig. 5, 1Ran1Crm11NXT1). Therefore, these data
indicate that NXT1 stimulation of nuclear export involves
release of both the NES receptor (Crm1) and the NES
substrate Rev–GR–GFP.
Interactions of NXT1 with the Crm1 Export Complex
We addressed the hypothesis that NXT1 physically inter-
acts with the export complex in a series of binding experi-
ments. Because NXT1 binds directly to Ran-GTP in vitro
(Black et al., 1999), and the latter is a stoichiometric com-
ponent of the export complex, we considered it possible
that Ran-GTP bridges or regulates the interaction be-
tween NXT1 and Crm1. We first tested the ability of re-
combinant NXT1 to bind 35S-labeled Crm1 synthesized in
reticulocyte lysate, using NXT1 immobilized in microtiter
wells. Crm1 displayed specific binding to NXT1, whereas
Crm1 binding to NTF2 was near background (Fig. 6 A).
Given that Crm1 and NXT1 are both Ran-GTP–binding
proteins, we examined whether the interaction requires
the GTP form of Ran. We tested this by pretreating the re-
action with excess recombinant RanGAP to convert Ran-
GTP to Ran-GDP. This reduced Crm1 binding to 45.5 6
0.4% of the untreated sample (Fig. 6 A). RanGAP-insen-
sitive binding of Crm1 to NXT1 may represent Ran-GTP–
independent interaction between these proteins, or that
Crm1-NXT1 complexes have the capacity to protect Ran-
GTP from RanGAP action.
We obtained evidence that NXT1 displays both Ran-
independent and -dependent interactions with Crm1 by
ELISA. Crm1 binding to NXT1 in the absence of Ran is
saturable, with an apparent KD z95 nM (Fig. 6 B), provid-
ing an explanation for the RanGAP-insensitive binding of
Crm1 to NXT1 (Fig. 6 A). However, Ran did stimulate
Crm1 binding to NXT1, which reduced the apparent KD of
this interaction to z30 nM (Fig. 6 B). To determine if
NXT1 can regulate the interaction of Crm1 with NES sub-
strate, we used an assay to measure direct binding of Crm1
to PKI, performed in the presence of Ran-GTP. Crm1
binding to the immobilized PKI, in this assay, is highly spe-
cific, since binding is blocked by LMB and the NES mutant
of PKI (L41,44A) shows only background level of binding
(Fig. 6 C, MUT). Including NXT1 in the reaction did not af-
fect the level of Crm1 binding to PKI (Fig. 6 C), even when
the assay was performed over a 100-fold concentration
range of Crm1 (Fig. 6 D). We also examined whether NXT1
affects Ran-GTP binding to Crm1, assayed in the presence
of NES substrate. Ran-GTP binding to immobilized Crm1
was saturable and increased only slightly in the presence of
NXT1 (Fig. 6 E). Our data demonstrate that whereas NXT1
binds directly to an export complex containing Crm1 and
Ran-GTP, it does not to play a primary role in regulating
NES recognition or promoting complex assembly.
Since we observed a cooperative effect of NXT1 and
RanBP1 in the release of Rev–GR–GFP from the NPC
(Fig. 3), we examined if these two proteins can directly in-
teract. We immobilized GST-RanBP1, GST-Ran, and GST
in microtiter wells, the latter proteins serving as controls
for binding specificity. Recombinant NXT1 bound to GST-
Ran, but not to immobilized GST-RanBP1, or to GST.
These data suggest the action of NXT1 and RanBP1 in the
release of export complexes from the NPC is unlikely to in-
volve a direct interaction between these proteins.
NXT1 Mutants Deficient in Crm1-mediated Export
Our mutational analysis of NXT1 was based on a struc-
tural model generated using the crystal structure of NTF2
(Bullock et al., 1996; Black et al., 1999). We designed point
mutations (N48E, E102N, and R107A) to alter highly con-
served residues in solvent-exposed loops that are pre-
dicted to be proximal to the Ran-binding domain of
NXT1. We also deleted four amino acids from the COOH
terminus of NXT1 (DDWAS), since the COOH terminus
of NTF2 helps stabilize Ran-GDP binding (Clarkson et al.,
1997). Finally, we mutated a phylogenetically conserved
lysine (K127A), whose spatial position is predicted to be
removed from the Ran-binding surface, in NXT1. We ex-
pressed and purified the mutant NXT1 proteins and char-Black et al. NXT1 Promotes the Terminal Step of Nuclear Export 151
acterized them using both nuclear export and binding as-
says, as described below.
We first examined the activity of the mutants using the
PKI export assay, which permits quantitative analysis of
export activity by measuring nuclear fluorescence at the
end of the export reaction (Black et al., 1999). We have de-
scribed multiple controls to show that the reduction in nu-
clear fluorescence reflects bona fide nuclear export (Ho-
laska and Paschal, 1998). We have also used the PKI assay
previously to show that wild-type NXT1 can stimulate nu-
clear export of PKI in the presence of a subsaturating con-
centration of HeLa cytosol (Black et al., 1999). We found
that the addition of recombinant Ran, Crm1, and NXT1 is
sufficient to promote nuclear export of biotinylated PKI
complexed with fluorescent STV (Fig. 7, A and B, bPKI/
FITC-STV-NLS). We assayed each of the NXT1 mutant
proteins in a similar manner, and determined that the
R107A and K127A mutants were severely deficient in
their ability to promote nuclear export of the PKI sub-
strate (Fig. 7 B). The E102N mutant was also significantly
reduced in export activity, whereas the N48E and DDWAS
mutants showed an intermediate level of export activity.
Figure 7. Mutant NXT1 proteins have reduced activity in the PKI
export assay. (A) NXT1 stimulates PKI export in the presence of re-
combinant Ran and Crm1. Fields of cells from PKI export reactions
performed with the indicated factors are shown for comparison. (B)
Quantitation of NXT1 and NXT1 mutant protein activity in NES-
dependent nuclear export. PKI assays were performed, and the
level of export was measured in z50 randomly selected postexport
nuclei and expressed as the mean nuclear fluorescence (6 SD). Ran
was used at 1.3 mM, Crm1 was used at 150 nM, and NXT1 proteins
were used at 14 mM.
Figure 8. NXT1 mutant proteins deficient in binding Ran and
Crm1. (A) Solid-phase Ran-GTP binding assays were performed
with immobilized NXT1 mutant proteins. Most NXT1 mutants
bind Ran-GTP with near wild-type affinity. However, the
COOH-terminal truncation (DDWAS) of NXT1 is deficient for
Ran-GTP binding. Wild-type NXT1 and NTF2 proteins serve as
controls in this experiment. Ran-GTP binding data for the
E102N mutant protein has been reported previously (Ossareh-
Nazari et al., 2000). (B) The R107A and COOH-terminal trunca-
tion NXT1 mutant proteins are deficient in binding Crm1. NXT1
mutant proteins were tested for their ability to bind radiolabeled
Crm1 in solid-phase binding assays. The Crm1-binding ability of
the R107A mutant protein is reduced, as is that of the COOH-
terminal truncation mutant (DDWAS).The Journal of Cell Biology, Volume 152, 2001 152
The reduced activity of NXT1 mutants is predicted to be
linked to reduced interactions with the export complex
containing Ran and Crm1. We evaluated this hypothesis in
solid-phase binding assays using wild-type NXT1 and mu-
tant NXT1 proteins immobilized in microtiter wells, and
NTF2 as a negative control. With the exception of the
COOH-terminal truncation mutant protein DDWAS, each
of the mutant proteins were able to bind Ran-GTP at lev-
els that were comparable to wild-type NXT1 (Fig. 8 A).
We next tested whether these immobilized NXT1 proteins
could interact with [35S]Crm1, which was synthesized in
reticulocyte lysate. The N48E, E102N, and K127A mu-
tants showed a slight reduction in Crm1 binding. Interest-
ingly, the DDWAS mutant that showed a reduction in
Ran-GTP binding was deficient for Crm1 binding as well
(Fig. 8 B). In contrast, we found that the R107A mutant,
which showed a wild-type activity for Ran-GTP binding,
was deficient for Crm1 binding. Taken together, our data
show that the COOH terminus of NXT1 is important for
its export function in permeabilized cells and for its inter-
actions with two components of the export complex, Ran-
GTP and Crm1. Arginine 107, which is conserved among
all known NXT1 orthologs (Black et al., 1999) and proba-
bly located on an exposed loop of the protein, appears to
be critical for binding Crm1.
The R107A Mutation in NXT1 Reduces 
Crm1-dependent RNA Export
We have shown previously that in addition to its role in
protein export, NXT1 also functions in RNA export (Os-
sareh-Nazari et al., 2000). Recombinant NXT1, when
added to a permeabilized cell assay that measures nuclear
transport of radiolabeled RNA, stimulates export of U1
snRNA, tRNA, and mRNA (Ossareh-Nazari et al., 2000).
Based on our present data, the function of NXT1 on these
export pathways is predicted to involve its interactions
with the export receptors. U1 snRNA export relies on
Crm1 as the receptor (Fornerod et al., 1997), explaining
why NXT1 stimulates export of this RNA substrate in
vitro (Ossareh-Nazari et al., 2000). tRNA export is medi-
ated by the importin-b superfamily member exportin-t,
whereas the identification of the receptor(s) for mRNA
export remains an area of active investigation. NXT1 has
also been shown to be an important cofactor for nuclear
export of viral RNA mediated by the receptor TAP (Kata-
hira et al., 1999; Bachi et al., 2000; Kang et al., 2000).
Therefore, NXT1 appears to play important roles in both
protein and RNA export pathways that involve several
different receptors (Ossareh-Nazari et al., 2000).
We examined the effect of the R107A mutation on the
export of three different RNA substrates: U1 snRNA,
mRNA, and tRNA. NXT1-dependent export of all three
RNA substrates is observed when the wild-type protein is
assayed in reactions that contain a subsaturating concen-
tration (15% by volume) of Xenopus cytosol. The R107A
NXT1 mutant showed a threefold reduction in its ability to
promote U1 snRNA export (Fig. 9). In contrast, the
R107A mutant promoted nuclear export of mRNA to the
same level as wild-type NXT1, and the R107A mutant pro-
tein was also active in promoting export of tRNA. These
results, together with the reduced activity of the R107A
mutant in the PKI export assay (Fig. 7) and the Crm1-
binding assay (Fig. 8 B), indicate that the export function
of NXT1 is specifically linked to its interaction with Crm1.
The reduced activity of the NXT1 mutant R107A in the
U1 snRNA export pathway, compared with mRNA and
tRNA export pathways, suggests it is possible to uncouple
its interactions with different export receptors.
Discussion
Here, we have shown that NXT1 is a cofactor for Crm1-
mediated protein export from the nucleus. By using re-
combinant proteins to characterize the factors required for
Figure 9. The R107A NXT1 mutant protein promotes mRNA
and tRNA export, but is reduced for U1 snRNA export. (A)
RNA export assays were performed in permeabilized HeLa cells
in the presence of the indicated concentrations of Xenopus egg
extracts. NXT1 proteins (17 mM) were added to the indicated
samples. Samples were separated into nuclear (N) or supernatant
(S) fractions and analyzed by denaturing gel electrophoresis. (B)
Quantitation of R107A mutant activity in stimulating the export
of different classes of RNA. The activity of wild-type (WT) and
R107A NXT1 proteins were quantitated by measuring the ratio
of RNA released to the supernatant (S) to the total RNA (N1S)
and subtracting the export observed in samples that had 15% ex-
tracts only. The export activity of the R107A mutant protein is
expressed as a percent relative to WT NXT1 activity. Whereas
the R107A mutant is capable of stimulating the Crm1-indepen-
dent export pathways (mRNA and tRNA) at levels similar to
WT NXT1, it is deficient in Crm1-dependent U1 snRNA export.Black et al. NXT1 Promotes the Terminal Step of Nuclear Export 153
nuclear export in permeabilized cells, we determined that
Crm1 and Ran are sufficient to reconstitute translocation
of the NES reporter Rev–GR–GFP from the nucleoli to
the cytoplasmic side of the NPC. Addition of NXT1 to the
export reaction, containing Crm1 and Ran, results in a sig-
nificant reduction in the level of Rev–GR–GFP at two to-
pologically distinct sites: within the nucleoli and associated
with the cytoplasmic side of the NPC. Thus, NXT1 activity
on the Crm1-dependent export pathway is manifest in
both the nucleoplasm and in the cytoplasm. The latter
clearly reflects NXT1-dependent release of Rev–GR–GFP
in a terminal step of export. The NXT1-dependent reduc-
tion in nucleolar fluorescence could indicate a role for
NXT1 in export complex assembly or targeting to the
NPC. Alternatively, it is possible that complex assembly
and targeting are delayed until the terminal step of NES-
substrate release is completed. NXT1 stimulates nuclear
export of diverse macromolecules transported via the
Crm1 pathway, which include the Rev and PKI proteins
(this study), as well as U1 snRNA (Ossareh-Nazari et al.,
2000). It seems likely that NXT1 serves as a cofactor for all
NES-containing substrates that undergo Crm1-dependent
export from the nucleus.
In addition to its role in Crm1-mediated export, NXT1
also participates directly in viral RNA export mediated by a
protein termed TAP (Katahira et al., 1999). Transcripts en-
coded by the Mason-Pfizer monkey virus contain a CTE
that functions as a cis-acting export signal (Hammarskjöld,
1997) that is recognized by TAP in the nucleus (Gruter et
al., 1998). A complex of TAP and NXT1 appears to bind
CTE-containing RNA and facilitates its export to the cyto-
plasm. Whether NXT1 performs analogous functions in the
Crm1 and TAP export pathways, the latter predicted to in-
volve release of CTE-containing RNA from the cytoplasmic
side of the NPC, is an important question for future study.
NXT1 Is a Cofactor for Crm1-dependent Export
The mechanism of NXT1-dependent export is likely to in-
volve its direct interactions with Ran-GTP and Crm1. All
three factors are necessary for efficient nuclear export, and
NXT1 can bind directly to Ran-GTP (Black et al., 1999)
and Crm1 (this study) in vitro. Moreover, the apparent KD
of Crm1 for NXT1 (90–100 nM) is reduced three- to four-
fold in the presence of Ran-GTP (25–35 nM), indicating
that these proteins display cooperative binding. Indepen-
dent evidence that Ran-GTP can regulate the interaction
between Crm1 and NXT1 was obtained in a solid-phase
binding assay using Crm1 translated in reticulocyte lysate.
We found that treating the lysate with excess RanGAP to
convert Ran-GTP to Ran-GDP significantly reduced Crm1
binding to NXT1. These data imply that Ran-GTP bridges
the interaction between Crm1 and NXT1, or that Ran-GTP
binding alters Crm1 to a conformation that is more favor-
able for binding NXT1. Our identification of a mutant
NXT1 (R107A) that is wild-type for Ran-GTP binding, but
deficient for Crm1 binding, suggests that NXT1 has binding
sites for both Ran-GTP and Crm1. We also found that
Crm1 binding to PKI in the presence of Ran-GMP-PNP,
which in our solid phase assay is specific for a wild-type
NES and inhibited by LMB, was unaffected by NXT1. We
conclude from this result that NXT1 does not stimulate the
initial formation of the export complex, however, we cannot
rule out the possibility that NXT1 affects export complex
stability, or targeting to the nuclear side of the NPC in vivo.
NXT1 Promotes NES Substrate Release from the NPC
Our experiments clearly demonstrate that NXT1 facilitates
the release of NES substrate in the terminal step of nuclear
export, which appears to be a rate-limiting step in this and
probably all export pathways. The first indication that NXT1
might function in this capacity came from our observation
that NXT1 reduces the Crm1/Ran-dependent accumulation
of Rev–GR–GFP at the NPC. Because this occurs under
conditions where the level of Rev–GR–GFP at nucleoli is
also reduced, NXT1 does not act as an inhibitor of Ran/
Crm1-dependent delivery of Rev–GR–GFP to the NPC.
Rather, NXT1 is a positively acting factor for nuclear export.
We used antibody detection of Rev–GR–GFP to dem-
onstrate that Crm1 and Ran are sufficient for delivery of
NES substrate to the cytoplasmic side of the NPC. In the
absence of the components necessary to release Rev–GR–
GFP from the NPC, we observe an accumulation of the
NES substrate on the cytoplasmic side of the NPC. We
found that addition of recombinant NXT1 was sufficient
to promote a substantial level of Rev–GR–GFP release
from the NPC, as assayed by fluorescence microscopy.
However, quantitative release of Rev–GR–GFP was only
observed in reactions containing HeLa cytosol, or in reac-
tions containing Crm1, Ran, NXT1, and RanBP1 (Fig. 3).
This result is interesting in light of the recent proposal that
RanBP1 plays a role in the terminal step of nuclear export
(Askjaer et al., 1999; Kehlenbach et al., 1999). Ran-GTP
in the context of an export complex is protected from Ran-
GAP-stimulated hydrolysis, and the addition of RanBP1
overcomes this protection (Askjaer et al., 1999; Paraskeva
et al., 1999), thereby acting as a RanGAP cofactor. Based
on these properties and the localization of RanGAP on
the cytoplasmic side of the NPC (Matunis et al., 1996; Ma-
hajan et al., 1997), conversion of Ran-GTP to Ran-GDP
by RanGAP and RanBP1 could trigger the disassembly of
the export complex in the terminal step of nuclear export.
Using purified proteins, it has been shown that Crm1 pre-
bound to an immobilized NES in the presence of Ran-GTP
can be released only if RanGAP and RanBP1 are added
(Askjaer et al., 1999). It has also been found that Crm1, ar-
rested at the NPC in the presence of the Ran mutant
Q69L, can be dissociated by addition of RanBP1 or a Ran-
binding domain from RanBP2 (Kehlenbach et al., 1999),
though this probably reflects a displacement rather than a
hydrolysis reaction. Our assay system, which detects the
release of Rev–GR–GFP from the cytoplasmic side of the
intact NPC, displays a dependence on both NXT1 and
RanBP1. NXT1 does not function as a coactivator of Ran-
GAP in vitro (Black et al., 1999), which, together with our
current findings, indicates the terminal step of export in-
volves more than Ran-GTP hydrolysis stimulated by Ran-
GAP. Including NXT1 in reactions with Crm1, Ran, and
RanBP1 also led to the reduction in the level of Crm1 de-
tected on the cytoplasmic face of the NPC (Fig. 5), indicat-
ing the entire export complex is released from the NPC.
On this note, it will be of interest to determine how release
of the export substrate may be coordinated with the re-
lease of Crm1 from the NPC, reactions that could occur ei-
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Model of NXT1 Function in NES Export
We have created a working model of nuclear export that in-
tegrates our molecular characterization of NXT1 with pre-
vious studies on Crm1 and other components of the path-
way (Fig. 10). Nuclear export is predicted to initiate in the
nucleoplasm with a series of protein–protein interactions
that ultimately terminate in the cytoplasm with the release
of NES substrate. The first step is Crm1 binding to NES
substrate, which is stabilized by Ran-GTP. We propose that
a second step of export includes the assembly of NXT1 into
the complex in the nucleoplasm, which is followed by its tar-
geting to the NPC. The third step of export is translocation
of the complex through the central channel of the NPC. The
fourth step is the disassembly of the complex, which results
in NES substrate release into the cytoplasm.
Our data supports the notion that NXT1 is not required
for the earliest step in the pathway, that is, the binding of
NES substrate to Crm1 in a complex that includes Ran-
GTP. This is based on our observation that NXT1 does not
affect Crm1 binding to PKI (Fig. 6 C). However, we pro-
pose that NXT1 engages the export complex before its de-
livery to the cytoplasmic side of the NPC, based on two re-
sults. First, in the order of addition experiment, NXT1
stimulates little release of Rev–GR–GFP that is preassem-
bled in a complex with Crm1 and Ran on the cytoplasmic
side of the NPC. In contrast, when NXT1, Crm1, and Ran-
GTP are added simultaneously to the reaction, we observe
nearly complete release of Rev–GR–GFP from the NPC.
This suggests that to exert its full release activity, NXT1
needs to interact with the export complex before its arrival
on the cytoplasmic side of the NPC. Second, NXT1 addi-
tion reduces the level of Rev–GR–GFP at the nucleolus.
We believe this indicates that NXT1 promotes a reaction
that precedes Rev–GR–GFP release, such as targeting to
the nuclear side of the NPC. It is also formally possible
that NXT1 reduces the level of Rev–GR–GFP at the nu-
cleolus by an indirect mechanism. For example, export
complex assembly in the nucleolus might be impeded until
substrate release from the cytoplasmic side of the NPC is
completed. This could be coordinated by a limiting com-
ponent for export complex assembly such as Crm1 that has
to be recycled from the cytoplasmic side of the NPC to the
nucleolus. Because NXT1 facilitates the release of Crm1
from the NPC, NXT1 could be involved, albeit indirectly,
in such a mechanism. However, it is unlikely that the pri-
mary function of NXT1 involves reimport of Crm1, since
Crm1 can undergo both import and export in our assay
system in the absence of NXT1. Nonetheless, linking ex-
port complex assembly, substrate release, and recycling is
an attractive mechanism for coordinating the distribution
and activity of export receptors and their regulators.
The current model of the terminal step of nuclear export,
release of NES substrate from the cytoplasmic side of the
NPC, relies on Ran-GTP as a key regulatory subunit that
dictates the assembly state of the export complex. RanBP1
and related domains in RanBP2 can destabilize, and possi-
bly dissociate, the interaction between Ran-GTP and Crm1
in the export complex. Ran-GTP is essential for high-affin-
ity binding of Crm1 to NES substrate (Fornerod et al.,
1997), and RanBP1 addition can stimulate the dissociation
of these proteins (Fig. 3) (Kehlenbach et al., 1999). Subse-
quent RanGAP-stimulated hydrolysis of Ran-GTP to Ran-
GDP makes the release reaction irreversible, because Crm1
fails to bind Ran-GDP. Our analysis revealed that RanBP1
was insufficient to stimulate the release reaction, as it had a
negligible effect in our assay, unless NXT1 was included as
well (Fig. 3). This indicates that NXT1 and RanBP1 per-
form distinct functions in the release reaction. One possibil-
ity is that NXT1 promotes transfer of the export complex
from a proximal accumulation site to a more distal site,
where RanBP1, RanBP2, and RanGAP can complete the
release reaction. In this scenario, NXT1, bound to an export
complex, would facilitate its forward progress within the
NPC. Determining whether NXT1- and RanBP1-facilitated
NES substrate and receptor release occur through a single
reaction step or through sequential reaction steps, and map-
ping the location of these intermolecular events within the
substructure of the NPC, should provide significant insight
into the mechanism of nuclear export.
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Figure 10. Model for steps in the Crm1-mediated
nuclear export pathway. The formation of a ter-
nary complex comprised of Crm1, Ran-GTP, and
NES-containing substrate (step 1) occurs in the nu-
cleoplasm, possibly independent of NXT1. NXT1
associates with the complex via direct interactions
with Ran-GTP and Crm1, and the complex is deliv-
ered to the NPC (step 2). Translocation through
the central gated channel of the NPC (step 3) can
occur independently of NXT1. However, NXT1 is
required for efficient release of the complex from
the cytoplasmic side of the NPC (step 4). The ex-
port reaction is terminated upon dissociation of the
complex; this appears to be facilitated by RanBP1
and RanGAP, or by a concerted action of the two
proteins. Conversion of Ran-GTP to Ran-GDP
makes the terminal step of export irreversible.Black et al. NXT1 Promotes the Terminal Step of Nuclear Export 155
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